David A Weitz

This inventor holds 86 USPTO granted patents and 60 published patent applications and 36 EPO patents, primarily in Microfluidics Technology (CPC class B01L3-502784). Top assignees: Harvard College, Vilnius University, The Brigham and Women's Hospital, Inc.. Active years: 2009-2024.

USPTO Granted Patents = 86 (Patent Applications = 60)

% Patents Active = 86.0

EPO Patents = 36 (Patent Applications = 73)

Average Co-Inventor Count = 4.0

ph-index = 21

Forward Citations = 2,823(Granted Patents)

Forward Citations (Not Self Cited) = 2,486(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Boston, MA (US) (2012 - 2023)
Bolton, MA (US) (2009 - 2024)
Cambridge, MA (US) (2024)

Company Filing History:

The Brigham and Women's Hospital, Inc.

patents

4. 3 out of 3,790

Johns Hopkins University

patents

5. 3 out of 8,568

Massachusetts Institute of Technology

patents

6. 3 out of 17,173

The Procter Gamble Company

University of Toronto

Massachusetts Eye and Ear Infirmary

patents

12. 1 out of 480

The Broad Institute, Inc.

patents

13. 1 out of 3,067

The General Hospital Corporation

patents

14. 1 out of 942

The University of New Mexico

patents

15. 1 out of 439

University of Cambridge

patents

16. 1 out of 124

University of Glasgow

patents

where one patent can have more than one assignee

Years Active: 2009-2024

Loading Chart...

Areas of Expertise:

Microfluidics

Droplet Production

Gene Sequencing

Nucleic Acid Analysis

Biomimetic Processing

Acoustic Waves

Colloids

Fluidic Manipulation

Barcoding Systems

Composite Techniques

Microspheres

Emulsions

86 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11952622 - Analysis of DNA-containing samples and resolution of mixed contributor DNA samples (2024-04-09),

2. 11878080 - Protein capsules (2024-01-23),

3. 11850589 - System and method for a biomimetic fluid processing (2023-12-26),

4. 11746367 - Barcoding systems and methods for gene sequencing and other applications (2023-09-05),

5. 11607658 - Formation of colloids or gels within droplets (2023-03-21),

6. 11597964 - Droplet-based method and apparatus for composite single-cell nucleic acid analysis (2023-03-07),

7. 11566214 - Systems and methods for biomimetic fluid processing (2023-01-31),

8. 11559806 - Acoustic wave sorting (2023-01-24),

9. 11517864 - Scale-up of microfluidic devices (2022-12-06),

10. 11401550 - Creation of libraries of droplets and related species (2022-08-02),

11. 11396016 - System and method for a biomimetic fluid processing (2022-07-26),

12. 11389800 - Systems and methods for droplet production and/or fluidic manipulation (2022-07-19),

13. 11229911 - Acoustic waves in microfluidics (2022-01-25),

14. 11155715 - Structurally colored materials with spectrally selective absorbing components and methods for making the same (2021-10-26),

15. 11141731 - Formation and control of fluidic species (2021-10-12),

Title: Innovator Spotlight: David A. Weitz - Pioneering Inventor in Biotechnology

Introduction:

David A. Weitz, a renowned inventor in the field of biotechnology, hails from Bolton, MA (US). With an impressive portfolio of 85 patents, Weitz has made significant contributions to the advancement of protein encapsulation and biomimetic fluid processing technologies.

Latest Patents:

One of Weitz's recent innovations includes Protein Capsules, featuring a shell material composed of protein assemblies. These capsules can also be equipped with an internal network of protein assemblies, obtained through protein aggregation. Additionally, his System and Method for Biomimetic Fluid Processing revolutionizes the harvesting of biological substances by creating precise fluid communication paths to generate optimal physiological shear rates.

Career Highlights:

Throughout his career, Weitz has been associated with esteemed institutions such as the President and Fellows of Harvard College and Vilnius University. His expertise and passion for innovation have led to the development of groundbreaking technologies that have the potential to shape the future of biotechnology.

Collaborations:

Weitz has collaborated with esteemed professionals in the field, including Adam R. Abate and Jeremy Agresti. Together, they have worked on cutting-edge projects that have pushed the boundaries of biotechnological research and development.

Conclusion:

In conclusion, David A. Weitz stands as a pioneering figure in the realm of biotechnology, with a remarkable track record of patents and inventions that have revolutionized the industry. His dedication to innovation and collaboration underscores his commitment to advancing scientific knowledge and technological possibilities.